litlas
Log inCreate account

Michaëla Diamant

Active 1993–2020

74
Papers
24,262
Citations
72
h-index
74
i10-index

Citations

Citations per year for Michaëla Diamant1994: 3 citations1995: 8 citations1996: 4 citations1997: 3 citations1998: 5 citations1999: 6 citations2000: 7 citations2001: 10 citations2002: 6 citations2003: 10 citations2004: 27 citations2005: 30 citations2006: 41 citations2007: 67 citations2008: 94 citations2009: 95 citations2010: 163 citations2011: 166 citations2012: 254 citations2013: 396 citations2014: 457 citations2015: 399 citations2016: 352 citations2017: 363 citations2018: 294 citations2019: 843 citations2020: 663 citations2021: 572 citations2022: 375 citations2023: 247 citations2024: 354 citations2025: 206 citations2026: 6 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,817 citing papers, 20.9% of this breakdownUnited Kingdom: 763 citing papers, 8.8% of this breakdownChina: 589 citing papers, 6.8% of this breakdownGermany: 473 citing papers, 5.5% of this breakdownNetherlands: 436 citing papers, 5% of this breakdownItaly: 432 citing papers, 5% of this breakdownCanada: 320 citing papers, 3.7% of this breakdownAustralia: 266 citing papers, 3.1% of this breakdownFrance: 264 citing papers, 3% of this breakdownDenmark: 249 citing papers, 2.9% of this breakdownJapan: 220 citing papers, 2.5% of this breakdownSweden: 198 citing papers, 2.3% of this breakdown
0%20.9%Other 30.5%

Institutions

Fields

  • Medicine79.2%
  • Biochemistry, Genetics and Molecular Biology11.7%
  • Neuroscience2.6%
  • Psychology2.1%
  • Health Professions0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Other3%

Topics

  • Diabetes Treatment and Management11.4%
  • Diabetes Management and Research6.2%
  • Pancreatic function and diabetes4.9%
  • Metabolism, Diabetes, and Cancer4.4%
  • Cardiovascular Function and Risk Factors4.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.6%
  • Other65.1%

Coauthors

All papers

Open in search
  1. GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

    Authors: Liselotte van Bloemendaal, Richard G. IJzerman, Jennifer S. ten Kulve, Frederik Barkhof, Robert J. Konrad, Madeleine L. Drent, Dick J. Veltman, Michaëla Diamant - Diabetes 2014 cited by 411

  2. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Authors: Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews - Diabetes Care 2014 cited by 3,078

  3. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

    Authors: Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews - Diabetes Care 2012 cited by 3,218

  4. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial

    Authors: C.A.J. van Beers, J. Hans DeVries, Susanne J. Kleijer, Mark M. Smits, Petronella Geelhoed-Duijvestijn, Mark H.H. Kramer, Michaëla Diamant, Frank J. Snoek, Erik H. Serné - The Lancet Diabetes & Endocrinology 2016 cited by 383

  5. Diastolic Stiffness of the Failing Diabetic Heart

    Authors: Loek van Heerebeek, Nazha Hamdani, M. Louis Handoko, Inês Falcão‐Pires, René J.P. Musters, Koba Kupreishvili, Alexander Ijsselmuiden, Casper G. Schalkwijk, Jean G.F. Bronzwaer, Michaëla Diamant, Attila Borbély, Jolanda van der Velden, Ger J.M. Stienen, Gerrit J. Laarman, Hans W.M. Niessen, Walter J. Paulus - Circulation 2007 cited by 731

  6. Altered Myocardial Substrate Metabolism and Decreased Diastolic Function in Nonischemic Human Diabetic Cardiomyopathy

    Authors: Luuk J. Rijzewijk, R.W. van der Meer, Hildo J. Lamb, Hugo W. A. M. de Jong, Mark Lubberink, Johannes A. Romijn, Jeroen J. Bax, Albert de Roos, Jos W. R. Twisk, Robert J. Heine, Adriaan A. Lammertsma, Johannes W. A. Smit, Michaëla Diamant - Journal of the American College of Cardiology 2009 cited by 308

  7. Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

    Authors: Mark M. Smits, Lennart Tonneijck, Marcel H.A. Muskiet, Mark H.H. Kramer, Petra J. W. Pouwels, Indra C. Pieters-van den Bos, Trynke Hoekstra, Michaëla Diamant, Daniël H. van Raalte, Djuna L. Cahen - Diabetologia 2016 cited by 140

  8. Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus

    Authors: Luuk J. Rijzewijk, R.W. van der Meer, Johannes W. A. Smit, Michaëla Diamant, Jeroen J. Bax, Sebastiaan Hammer, Johannes A. Romijn, Albert de Roos, Hildo J. Lamb - Journal of the American College of Cardiology 2008 cited by 552

  9. Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

    Authors: Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Michaëla Diamant, Jaap A. Joles, Daniël H. van Raalte - Diabetologia 2016 cited by 128

  10. Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes

    Authors: Max Nieuwdorp, Hans L. Mooij, Jojanneke Kroon, Bektaş Atasever, Jos A. E. Spaan, Can İnce, F. Holleman, Michaëla Diamant, Robert J. Heine, J. B. L. Hoekstra, John J.P. Kastelein, Erik S.G. Stroes, Hans Vink - Diabetes 2006 cited by 434

  11. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Authors: Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, Ele Ferrannini, Michael A. Nauck, Anne L. Peters, Απόστολος Τσάπας, Richard C. Wender, David R. Matthews - Diabetologia 2015 cited by 690

  12. Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

    Authors: Michaëla Diamant, Luc Van Gaal, Stephen Stranks, Justin Northrup, Dachuang Cao, Kristin Taylor, Michael Trautmann - The Lancet 2010 cited by 436

  13. Pancreatic Fat Content and β-Cell Function in Men With and Without Type 2 Diabetes

    Authors: Maarten E. Tushuizen, Mathijs C. Bunck, Petra J. W. Pouwels, Saskia Bontemps, Jan Hein T. van Waesberghe, Roger K. Schindhelm, Andrea Mari, Robert J. Heine, Michaëla Diamant - Diabetes Care 2007 cited by 394

  14. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Authors: S. E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaëla Diamant, E. Ferrannini, M. Nauck, Anne L. Peters, Απόστολος Τσάπας, R. Wender, David R. Matthews - Diabetologia 2012 cited by 3,932

  15. Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

    Authors: Mathijs C. Bunck, Michaëla Diamant, Björn Eliasson, A. H. Corner, Rimma M. Shaginian, Robert J. Heine, Marja‐Riitta Taskinen, Hannele Yki‐Järvinen, Ulf Smith - Diabetes Care 2010 cited by 156

  16. The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?

    Authors: Marcel H.A. Muskiet, Mark M. Smits, Linde M. Morsink, Michaëla Diamant - Nature Reviews Nephrology 2013 cited by 177

  17. Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing

    Authors: Mark Fineman, Shawn Flanagan, Kristin Taylor, Maria Aisporna, Larry Z. Shen, Kenneth Mace, Brandon Walsh, Michaëla Diamant, Brenda Cirincione, Prajakti A. Kothare, Wen-I Li, Leigh MacConell - Clinical Pharmacokinetics 2010 cited by 135

  18. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

    Authors: Lennart Tonneijck, Mark M. Smits, Marcel H.A. Muskiet, Trynke Hoekstra, Mark H.H. Kramer, A.H. Jan Danser, Piet M. ter Wee, Michaëla Diamant, Jaap A. Joles, Daniël H. van Raalte - Diabetes Care 2016 cited by 114

  19. Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner

    Authors: Marc C. Huisman, Larissa W. van Golen, Nikie J. Hoetjes, Henri N. Greuter, Patrick Schober, Richard G. IJzerman, Michaëla Diamant, Adriaan A. Lammertsma - EJNMMI Research 2012 cited by 83

  20. One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients

    Authors: Mathijs C. Bunck, Michaëla Diamant, A. H. Corner, Björn Eliasson, Jaret Malloy, Rimma M. Shaginian, Wei Deng, David M. Kendall, Marja‐Riitta Taskinen, Ulf Smith, Hannele Yki‐Järvinen, Robert J. Heine - Diabetes Care 2009 cited by 387

  21. Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus

    Authors: R.W. van der Meer, Luuk J. Rijzewijk, Hugo W. A. M. de Jong, Hildo J. Lamb, Mark Lubberink, Johannes A. Romijn, Jeroen J. Bax, Albert de Roos, Otto Kamp, Walter J. Paulus, Robert J. Heine, Adriaan A. Lammertsma, Johannes W. A. Smit, Michaëla Diamant - Circulation 2009 cited by 238

  22. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes

    Authors: Jennifer S. ten Kulve, Dick J. Veltman, Liselotte van Bloemendaal, Frederik Barkhof, Carolyn F. Deacon, Jens J. Holst, Robert J. Konrad, John H. Sloan, Madeleine L. Drent, Michaëla Diamant, Richard G. IJzerman - Diabetologia 2015 cited by 108

  23. Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes

    Authors: Jennifer S. ten Kulve, Dick J. Veltman, Liselotte van Bloemendaal, Frederik Barkhof, Madeleine L. Drent, Michaëla Diamant, Richard G. IJzerman - Diabetes Care 2015 cited by 94

  24. Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

    Authors: Roger K. Schindhelm, Michaëla Diamant, Joost Dekker, Maarten E. Tushuizen, Tom Teerlink, Robert J. Heine - Diabetes/Metabolism Research and Reviews 2006 cited by 378